Profile
J.
Christopher Love is the founder of Enumeral Biomedical Corp.
(founded in 2009) and Sunflower Therapeutics, Pbc (founded in 2018).
He is currently an Associate Professor at Massachusetts Institute of Technology.
He obtained a doctorate degree from Harvard University.
J. Christopher Love active positions
| Companies | Position | Start |
|---|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
Sunflower Therapeutics, Pbc
Sunflower Therapeutics, Pbc Industrial MachineryProducer Manufacturing Operates automated single-use bioreactor systems and provides biotechnology services | Founder | 2017-12-31 |
Former positions of J. Christopher Love
| Companies | Position | End |
|---|---|---|
Enumeral Biomedical Corp.
Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases | Founder | - |
Training of J. Christopher Love
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Enumeral Biomedical Corp.
Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases | Commercial Services |
Sunflower Therapeutics, Pbc
Sunflower Therapeutics, Pbc Industrial MachineryProducer Manufacturing Operates automated single-use bioreactor systems and provides biotechnology services | Producer Manufacturing |
- Stock Market
- Insiders
- J. Christopher Love
















